Yongqi Deng

Founder & CEO

Professional Overview

Yongqi Deng is an accomplished pharmaceutical industry veteran with over 20 years of experience in drug discovery and development. As the Founder and CEO of Keythera Pharmaceuticals, he leverages his deep expertise in medicinal chemistry and strategic leadership to drive innovative research and bring novel therapeutics to market.

Experience Summary

Current Role

As the Founder and CEO of Keythera Pharmaceuticals Co., Ltd. since 2018, Yongqi is responsible for the overall strategic direction, operational management, and business development of the company. Under his leadership, Keythera has built a robust pipeline of drug candidates targeting various therapeutic areas, including oncology and rare diseases. Yongqi's visionary approach and strong scientific acumen have been instrumental in securing significant funding and strategic partnerships to accelerate Keythera's growth and impact.

Career Progression

Prior to founding Keythera, Yongqi held progressive roles in leading pharmaceutical organizations, including Merck, Schering-Plough Research Institute, NeoGenesis Pharmaceuticals, and Polaroid. As an Exploratory Medicinal Chemist at Merck, he played a key role in the discovery and optimization of several drug candidates, contributing to the advancement of the company's pipeline. During his tenure at Schering-Plough and NeoGenesis, Yongqi demonstrated his scientific expertise and leadership abilities, driving innovative research and contributing to the development of novel therapeutic solutions.

Academic Background

Yongqi holds a Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology, where he conducted groundbreaking research as a Postdoctoral Associate. His specialized knowledge and academic achievements have provided a strong foundation for his success in the pharmaceutical industry.

Areas of Expertise

• Medicinal chemistry and drug discovery

• Exploratory research and lead optimization

• Therapeutic development in oncology and rare diseases

• Strategic planning and business development

• Effective team leadership and collaboration

Professional Impact

Under Yongqi's guidance, Keythera Pharmaceuticals has established a reputation for its innovative approaches to drug discovery and development. The company has successfully secured several strategic partnerships and has advanced multiple drug candidates through preclinical and clinical stages, positioning it as a rising player in the pharmaceutical industry.

Conclusion

Yongqi Deng's extensive experience, scientific expertise, and visionary leadership have made him a respected figure in the pharmaceutical industry. As the Founder and CEO of Keythera Pharmaceuticals, he is dedicated to driving the development of transformative therapies that address unmet medical needs and improve patient outcomes.